Publications and Digital Products

This Joint SAMHSA-CMS informational Bulletin provides guidance to states and school systems about addressing mental health and substance use issues in schools. It provides examples of approaches for services in schools and describes some Medicaid authorities that states may use to cover services.

This guide provides strategies for clinicians who provide substance use disorder treatment to people who have experienced child abuse and child neglect. It lists symptoms of child abuse and neglect and presents screening questions, behavioral clues, and the role of child protective services.

This guide educates substance use counselors and clinicians about detoxification and withdrawal. It addresses patient placement, detox services for specific substances, co-occurring disorders, financing issues, and screening and assessment tools.

This guide reviews screening tools for alcohol use and interventions for pregnant women and women of childbearing age to prevent fetal alcohol spectrum disorders (FASD). It also outlines methods for identifying people living with FASD and modifying treatment accordingly. Access the literature review.

This manual offers guidelines to help counselors and administrators deliver substance use disorder treatment in criminal justice settings. It discusses aspects in providing substance use disorder treatment to people within the criminal justice system, including screening and assessment, and triage and placement in treatment services.

This manual offers practice guidelines and recommendations for integrating employment services into substance use disorder treatment. It also provides information about funding, policy, and legal issues.

This manual helps clinicians improve care for people living with HIV/AIDS and substance use disorder conditions. It discusses prevention, assessment, and treatment of HIV/AIDS. The manual also examines mental illness, integrated services, case management, counseling, ethical and legal issues, and funding sources.

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

This advisory equips substance use treatment and service providers with information about eating disorders and their relationship to substance use disorders. It provides an overview of screening, referrals, and evidence-based treatments for eating disorders and lists resources for more information.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.